Aurobindo Pharma has reported results for third quarter ended December 31, 2016.
The company has reported 4.98% fall in its net profit at Rs 441.02 crore for the quarter under review as compared to Rs 464.14 crore for the same quarter in the previous year. However, total income of the company increased by 4.99% at Rs 2523.40 crore for the quarter under review as compared Rs 2403.48 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 6.30% rise in its net profit after tax, minority interest and share of profit of associates at Rs 578.59 crore for the quarter ended December 31, 2016, as compared to Rs 544.31 crore for the same quarter in the previous year. Total income of the company increased by 11.41% at Rs 3914.10 crore for the quarter under review as compared Rs 3513.14 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |